---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-122454"
form_type: "8-K"
ticker: "QURE"
cik: "0001590560"
company_name: "uniQure N.V."
filed_at: "2022-11-28T23:59:59+00:00"
generated_at: "2026-06-21T12:45:34.188408+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BMS terminates collaboration with uniQure effective Feb 21, 2023

## Summary
- Bristol-Myers Squibb provided termination notice for collaboration and license agreement originally dated May 2015.
- Termination is effective February 21, 2023; the agreement was amended in December 2020.
- BMS did not replace any of the four active Collaboration Targets during the one-year option period.
- A change-of-control payment of up to $70M to BMS is still contingent; no such transaction has occurred.
- The separate Investor Agreement between uniQure and BMS remains in force per its terms.

## SEC filing metadata
- accession: 0001104659-22-122454
- form_type: 8-K
- ticker: QURE
- cik: 0001590560
- company_name: uniQure N.V.
- filed_at: 2022-11-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590560/000110465922122454/0001104659-22-122454-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590560/000110465922122454/tm2231450d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-122454
- JSON: https://secwatch.observer/filing/0001104659-22-122454.json
- Plain text: https://secwatch.observer/filing/0001104659-22-122454.txt

## Key facts
- Material Agreements
  uniQure N.V. terminated BMS CLA with Bristol-Myers Squibb (effective 2023-02-21).
  - Action: termination
  - Agreement: license
  - Counterparty: Bristol-Myers Squibb
  - Effective: 2023-02-21
  source text: On November 21, 2022, BMS provided, and the Company received, a notice that the BMS CLA, as amended, will terminate effective February 21, 2023 (the “Termination Notice”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1590560/000110465922122454/0001104659-22-122454-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.